MAXIDEX 1mg / ml ophthalmic drops suspension medication leaflet

S01BA01 dexamethasone • Sensory organs | Antiinflammatory agents | Corticosteroids, plain

Dexamethasone is a potent corticosteroid used to treat a wide range of inflammatory, allergic, and autoimmune conditions. It is also used in the treatment of certain cancers, cerebral edema, septic shock, and for the prevention and treatment of chemotherapy-induced nausea and vomiting.

It works by suppressing the body's inflammatory and immune response, reducing inflammation, swelling, redness, and allergic reactions. It is available in the form of tablets, injectable solutions, eye or nasal drops, and ointments.

Side effects may include weight gain, fluid retention, high blood pressure, hyperglycemia, insomnia, weakened immune system, osteoporosis, or, in rare cases, psychiatric disturbances (anxiety, depression). Long-term use can lead to severe side effects, such as Cushing's syndrome.

Dexamethasone is contraindicated in untreated systemic infections and should be used with caution in patients with diabetes, hypertension, osteoporosis, or gastric ulcers. It is important to take it as prescribed by a doctor, and discontinuation should be done gradually to avoid withdrawal effects.

General data about MAXIDEX 1mg / ml

Substance: dexamethasone

Date of last drug list: 01-06-2025

Commercial code: W70670001

Concentration: 1mg / ml

Pharmaceutical form: ophthalmic drops suspension

Packing volume: 5ml

Product type: original

Price: 7.57 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ALCON-COUVREUR N.V. - BELGIA

Holder: NOVARTIS EUROPHARM LIMITED - IRLANDA

Number: 11112/2018/01

Shelf life: 3 years

Concentrations available for dexamethasone

0.1%, 0.5mg, 0.985mg/g, 1.5mg/ml, 1mg/ml, 20mg, 40mg, 4mg, 4mg/ml, 700mcg, 8mg, 8mg/2ml

Compensation lists for MAXIDEX 1mg / ml EUROPHARM

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

7.57 RON

3.79 RON

3.79 RON

NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment

Price

Copayment

Patient

7.57 RON

7.57 RON

0.00 RON